The Drug-Induced Respiratory Disease Website

VII - Cardiotoxicity

VII.a

‘Cardiotoxicity’

1

Evidence level

low

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

2

Evidence level

possible

X.d

Fluid retention

1

Evidence level

low

X.i

Pulmonary edema/ARDS of the ATRA syndrome

1

Evidence level

low

XII - Pericardial involvement

XII.b

Pericardial effusion (w/wo tamponade)

1

Evidence level

low

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)

1

Evidence level

low

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

2

Evidence level

possible

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

2

Evidence level

possible

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

1

Evidence level

low